share_log

EF Hutton Initiates Coverage On GT Biopharma With Hold Rating, Announces Price Target of $2

EF Hutton Initiates Coverage On GT Biopharma With Hold Rating, Announces Price Target of $2

EF Hutton以持有評級啟動對GT Biophma的覆蓋,宣佈目標價為2美元
Benzinga Real-time News ·  2023/01/05 04:32

EF Hutton analyst Tony Butler initiates coverage on GT Biopharma (NASDAQ:GTBP) with a Hold rating and announces Price Target of $2.

EF Hutton分析師Tony·巴特勒對GT Biophma(納斯達克:GTBP)發起持有評級,並宣佈目標價為2美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論